Literature DB >> 19019929

The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure.

D Colville1, Y Y Wang, R Tan, J Savige.   

Abstract

BACKGROUND AND AIMS: Alport syndrome is an inherited disease with renal failure, and often a hearing loss, lenticonus and dot-and-fleck retinopathy. A retinal "lozenge" or "dull macular reflex" has been described in some patients. This study determined the prevalence and significance of this sign.
METHODS: Twenty-three patients from 14 families with X linked Alport syndrome and seven from four families with autosomal recessive disease underwent slit-lamp biomicroscopy for lenticonus, direct and indirect ophthalmoscopy, and photography for the retinopathy.
RESULTS: The lozenge was present in five males (38%) but no females with X linked Alport syndrome, as well as one individual with recessive disease (1/7, 14%). It resulted from the sharp demarcation between the normal fovea and a perifoveal annnulus of confluent dots and flecks that were obvious with magnification of retinal photographs. The lozenge was first noted in adolescence and was always associated with early-onset renal failure, hearing loss and lenticonus.
CONCLUSION: Clinicians must be aware that the "lozenge" or "dull macular reflex" described in Alport syndrome is not a normal variant but reflects a severe, almost confluent perimacular dot and fleck retinopathy. This sign is useful diagnostically and also prognostically, since it is associated with early-onset renal failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019929     DOI: 10.1136/bjo.2008.142869

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

2.  Alport retinopathy results from "severe" COL4A5 mutations and predicts early renal failure.

Authors:  Rachel Tan; Deb Colville; Yan Yan Wang; Lin Rigby; Judy Savige
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

Review 3.  Opinion: Ocular features aid the diagnosis of Alport syndrome.

Authors:  Judy Savige; Deb Colville
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

4.  Temporal macular thinning associated with X-linked Alport syndrome.

Authors:  Faisal Ahmed; Kandon K Kamae; Denise J Jones; Margaret M Deangelis; Gregory S Hageman; Martin C Gregory; Paul S Bernstein
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

5.  Characterization of Choriocapillaris and Choroidal Abnormalities in Alport Syndrome.

Authors:  Maria Vittoria Cicinelli; Markus Ritter; Hassan Tausif; Cybele Ghossein; Constantin Aschauer; Franco Laccone; Mato Nagel; Lee M Jampol; Manjot K Gill
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

Review 6.  Ocular Manifestations and Potential Treatments of Alport Syndrome: A Systematic Review.

Authors:  Rahul Ramakrishnan; Atira Shenoy; Damon Meyer
Journal:  J Ophthalmol       Date:  2022-09-08       Impact factor: 1.974

7.  Increased Subfoveal Choroidal Thickness and Retinal Structure Changes on Optical Coherence Tomography in Pediatric Alport Syndrome Patients.

Authors:  Seda Karaca Adıyeke; Gamze Ture; Fatma Mutlubaş; Hasan Aytoğan; Onur Vural; Neslisah Kutlu Uzakgider; Gulsah Talay Dayangaç; Ekrem Talay
Journal:  J Ophthalmol       Date:  2019-01-21       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.